SALICYLIC ACID 2% /SODIUM SULFACETAMIDE MONOHYDRATE 8%- salicylic acid 2% /sodium sulfacetamide monohydrate 8% suspension 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

SALICYLIC ACID 2% /SODIUM SULFACETAMIDE MONOHYDRATE 8%

Directions for use

x

Sincerus Florida. Adverse Reactions

w

Active, Inactive

x

NDC 72934-8170-6 SALICYLIC ACID 2% /SODIUM SULFACETAMIDE MONOHYDRATE 8% Suspension 120 gm

x

SALICYLIC ACID 2% /SODIUM SULFACETAMIDE MONOHYDRATE 8% 
salicylic acid 2% /sodium sulfacetamide monohydrate 8% suspension
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-8170
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SULFACETAMIDE SODIUM (UNII: 4NRT660KJQ) (SULFACETAMIDE - UNII:4965G3J0F5) SULFACETAMIDE SODIUM8 g  in 100 g
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 g  in 100 g
Product Characteristics
ColoryellowScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-8170-6120 g in 1 CYLINDER; Type 0: Not a Combination Product05/01/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/01/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-8170)

Revised: 4/2019
Document Id: 87390b9e-a525-2e36-e053-2a91aa0affe2
Set id: 87395273-37fa-7cef-e053-2991aa0a54c6
Version: 1
Effective Time: 20190423
 
Sincerus Florida, LLC